{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T22:59:30Z","timestamp":1776466770201,"version":"3.51.2"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.nut.2020.111020","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T11:21:33Z","timestamp":1600082493000},"page":"111020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Compatibility of intravenous metronidazole with some all-in-one parenteral nutrition regimens"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5986-7544","authenticated-orcid":false,"given":"Katarzyna","family":"Dettlaff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5106-5937","authenticated-orcid":false,"given":"Maciej","family":"Stawny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Gosty\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Popielarz-Brzezi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Ogrodowczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nut.2020.111020_bib0001","unstructured":"World Health Organization. Essential medicines. Available at: https:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en\/. Accessed August 2, 2019."},{"key":"10.1016\/j.nut.2020.111020_bib0002","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s15010-009-8116-5","article-title":"Continuous vs thrice-daily ceftazidime for elective intravenous antipseudomonal therapy in cystic fibrosis","volume":"37","author":"Riethmueller","year":"2009","journal-title":"Infection"},{"key":"10.1016\/j.nut.2020.111020_bib0003","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jac\/dkp139","article-title":"Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution","volume":"64","author":"Roberts","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nut.2020.111020_bib0004","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1586\/eri.13.44","article-title":"Extended or continuous versus short-term intravenous infusion of cephalosporins: a meta-analysis","volume":"11","author":"Korbila","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.nut.2020.111020_bib0005","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1016\/j.eclnm.2009.01.008","article-title":"Basics in clinical nutrition: Drugs and nutritional admixtures","volume":"4","author":"M\u00fchlebach","year":"2009","journal-title":"E Spen Eur E J Clin Nutr Metab"},{"key":"10.1016\/j.nut.2020.111020_bib0006","series-title":"Basics in clinical nutrition","first-page":"345","article-title":"Pharmaceutical aspects of parenteral nutrition support","year":"2019"},{"key":"10.1016\/j.nut.2020.111020_bib0007","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/0148607114521833","article-title":"A.S.P.E.N. clinical guidelines: parenteral nutrition ordering, order review, compounding, labeling, and dispensing","volume":"38","author":"Boullata","year":"2014","journal-title":"JPEN"},{"key":"10.1016\/j.nut.2020.111020_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190577","article-title":"Compatibility of intravenous ibuprofen with lipids and parenteral nutrition, for use as a continuous infusion","volume":"13","author":"Garcia","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.nut.2020.111020_bib0009","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jpen.1419","article-title":"Physicochemical compatibility of amiodarone with parenteral nutrition","volume":"43","author":"Mediavilla","year":"2019","journal-title":"JPEN"},{"key":"10.1016\/j.nut.2020.111020_bib0010","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/ncp.10013","article-title":"Physicochemical stability and sterility of standard parenteral nutrition solutions and simulated Y-site admixtures for neonates","volume":"33","author":"Riera","year":"2018","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.nut.2020.111020_bib0011","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/jphp.12647","article-title":"Physical compatibility of total parenteral nutrition in Y-site administration to children from neonates to adolescents","volume":"69","author":"Staven","year":"2017","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.nut.2020.111020_bib0012","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/nu11030559","article-title":"Effect of lipid emulsion on stability of ampicillin in total parenteral nutrition","volume":"11","author":"Stawny","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.nut.2020.111020_bib0013","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3390\/pharmaceutics12030292","article-title":"Safe practice of Y-site drug administration: the case of colistin and parenteral nutrition","volume":"12","author":"Stawny","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nut.2020.111020_bib0014","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/0148607112464239","article-title":"Compatibility of intravenous medications with parenteral nutrition: in vitro evaluation","volume":"37","author":"Bouchoud","year":"2013","journal-title":"JPEN"},{"key":"10.1016\/j.nut.2020.111020_bib0015","series-title":"European Pharmacopoeia 9.0","year":"2017"},{"key":"10.1016\/j.nut.2020.111020_bib0016","first-page":"499","article-title":"Application of validated stability indicating HPLC method in stability testing of nor-metrogyl tablets","volume":"3","author":"Chavakula","year":"2013","journal-title":"J Pharm Res"},{"key":"10.1016\/j.nut.2020.111020_bib0017","doi-asserted-by":"crossref","first-page":"45","DOI":"10.11113\/jt.v72.3071","article-title":"Liquid chromatography with UV detection for simultaneous determination of ciprofloxacin and metronidazole","volume":"72","author":"Budiarti","year":"2014","journal-title":"J Teknol"},{"key":"10.1016\/j.nut.2020.111020_bib0018","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/chromsci\/bmw113","article-title":"A rapid and validated RP-HPLC method for the simultaneous quantification of benzoic acid, metronidazole and miconazole nitrate in vaginal formulations","volume":"54","author":"Sahoo","year":"2016","journal-title":"J Chromatogr Sci"},{"key":"10.1016\/j.nut.2020.111020_bib0019","series-title":"Proceedings of the International Conference on Harmonization (ICH) of Technical Requirements for registration of Pharmaceuticals for Human Use","article-title":"Topic Q2(R1): Validation of Analytical Procedures: Text and Methodology","year":"2005"},{"key":"10.1016\/j.nut.2020.111020_bib0020","series-title":"United States pharmacopeia and national formulary","year":"2015"},{"key":"10.1016\/j.nut.2020.111020_bib0021","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clnu.2016.01.020","article-title":"ESPEN guidelines on chronic intestinal failure in adults","volume":"35","author":"Pironi","year":"2016","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2020.111020_bib0022","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12937-016-0149-x","article-title":"Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugs","volume":"15","author":"Staven","year":"2016","journal-title":"Nutr J"},{"key":"10.1016\/j.nut.2020.111020_bib0023","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1093\/ajhp\/53.19.2339a","article-title":"Don't ignore details of drug-compatibility reports","volume":"53","author":"Kohut","year":"1996","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.nut.2020.111020_bib0024","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/415310","article-title":"Pharmaceutical point of view on parenteral nutrition","author":"Stawny","year":"2013","journal-title":"Sci World J"},{"key":"10.1016\/j.nut.2020.111020_bib0025","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/jn\/112.8.1631","article-title":"Formation of Maillard reaction products in parenteral alimentation solutions","volume":"112","author":"Fry","year":"1982","journal-title":"J Nutr"},{"key":"10.1016\/j.nut.2020.111020_bib0026","first-page":"383","article-title":"Colour difference \u0394E-A survey","volume":"20","author":"Mokrzycki","year":"2011","journal-title":"Mach Graph Vis"},{"key":"10.1016\/j.nut.2020.111020_bib0027","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-5173(01)00626-3","article-title":"Physicochemical assessments of parenteral lipid emulsions: light obscuration versus laser diffraction","volume":"219","author":"Driscoll","year":"2001","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nut.2020.111020_bib0028","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0378-5173(92)90240-3","article-title":"The electrokinetic properties of phospholipid stabilized fat emulsions VI. Zeta potentials of Intralipid 20% in TPN mixtures","volume":"87","author":"Washington","year":"1982","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nut.2020.111020_bib0029","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2710.1993.tb00602.x","article-title":"Emulsion stability in total parenteral nutrition mixtures compounded from the fat emulsion \u2018Elolipid\u00ae 20%\u2019","volume":"18","author":"Washington","year":"1993","journal-title":"J Clin Pharm Therap"},{"key":"10.1016\/j.nut.2020.111020_bib0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0378-5173(90)90271-5","article-title":"The electrokinetic properties of phospholipid stabilized fat emulsions. IV. The effect of glucose and of pH","volume":"64","author":"Washington","year":"1990","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nut.2020.111020_bib0031","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0378-5173(91)90301-4","article-title":"The electrokinetic properties of phospholipid stabilized fat emulsions. V. The effect of amino acids on emulsion stability","volume":"77","author":"Washington","year":"1991","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nut.2020.111020_bib0032","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0169-409X(95)00116-O","article-title":"Stability of lipid emulsions for drug delivery","volume":"20","author":"Washington","year":"1996","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nut.2020.111020_bib0033","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ejps.2016.10.015","article-title":"Physicochemical stability and compatibility testing of levetiracetam in all-in-one parenteral nutrition admixtures in daily practice","volume":"96","author":"Aeberhard","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nut.2020.111020_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24071242","article-title":"Physicochemical compatibility and stability of linezolid with parenteral nutrition","volume":"24","author":"Tomczak","year":"2019","journal-title":"Molecules"}],"container-title":["Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900720303038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900720303038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:14:51Z","timestamp":1760271291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899900720303038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":34,"alternative-id":["S0899900720303038"],"URL":"https:\/\/doi.org\/10.1016\/j.nut.2020.111020","relation":{},"ISSN":["0899-9007"],"issn-type":[{"value":"0899-9007","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Compatibility of intravenous metronidazole with some all-in-one parenteral nutrition regimens","name":"articletitle","label":"Article Title"},{"value":"Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nut.2020.111020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111020"}}